Is the prescribed meloxicam 7.5 mg tablet to be taken orally once daily as needed for pain, with a 90‑day supply and one refill appropriate?

Meloxicam Prescription Assessment

This prescription contains a critical error: meloxicam should NOT be prescribed "as needed" (PRN) for chronic pain management—it must be taken daily on a scheduled basis to maintain therapeutic anti-inflammatory levels. 1, 2

Primary Concerns with This Prescription

Dosing Schedule Error

• Meloxicam requires once-daily scheduled dosing, not PRN administration 1, 3
• The drug has a plasma half-life of approximately 20 hours, making it suitable for once-daily administration but requiring consistent daily use to maintain therapeutic levels 3
• PRN dosing undermines the anti-inflammatory mechanism and increases GI toxicity risk without providing adequate pain control 4
• Correct instruction should read: "Take 1 tablet orally once daily" (remove "as needed") 2, 5

Appropriate Dosing Range

• The 7.5 mg starting dose is appropriate and follows standard guidelines 4, 1
• This dose can be increased to a maximum of 15 mg daily if necessary for adequate symptom control 1, 2
• The 7.5 mg dose is specifically recommended for elderly patients as the maximum dose 1
• Studies demonstrate that 7.5 mg meloxicam is effective for osteoarthritis and provides GI tolerability comparable to placebo 2

Gastrointestinal Risk Considerations

Risk Stratification Required

• Before dispensing, assess the patient's GI bleeding risk factors: age >65, history of peptic ulcer disease, concurrent anticoagulant use, or history of NSAID-related GI bleeding 4
• The one-year risk of serious GI bleeding ranges from 1 in 2,100 in adults <45 years to 1 in 110 in adults >75 years 4
• Concomitant anticoagulant use increases GI bleeding risk 5-6 fold 4

Gastroprotection Strategy

• If any GI risk factors are present, add a proton pump inhibitor (PPI) to the regimen 4
• Patients with prior NSAID-related upper GI bleeding have a 5% risk of recurrent bleeding within 6 months even with gastroprotection 4
• Consider avoiding NSAIDs entirely in patients with recent GI bleeding history 4

Cardiovascular Considerations

• All NSAIDs, including meloxicam as a preferential COX-2 inhibitor, carry cardiovascular risks 4
• Assess for cardiovascular disease, hypertension, or heart failure before prescribing 4
• Use the lowest effective dose for the shortest duration necessary 4

Duration and Refill Appropriateness

• A 90-day supply with one refill (180 days total) is reasonable for chronic conditions like osteoarthritis 1, 2
• However, reassessment should occur before the refill is authorized to evaluate ongoing need, efficacy, and adverse effects 4
• For acute pain conditions, shorter durations are more appropriate 4

Corrected Prescription Should Read:

Meloxicam 7.5 mg Tablet
Take: 1 tablet orally once daily (scheduled, not PRN)
Duration: 90 days
Dispense: 90 tablets
Refill: 1 (with reassessment)

Add PPI if patient has any GI risk factors 4